A new guideline from the American Academy of Neurology will help people who take blood thinners decide whether or not to take them during surgery or other medical procedures. The guideline is published in the May 28, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology.
People who have had a stroke often take blood thinners such as aspirin or warfarin to prevent another stroke. Blood thinners, or anticlotting drugs, are also used to prevent a first stroke in people with atrial fibrillation, an irregular or fast heartbeat. Blood thinners can prevent blood clots from forming that can cause strokes. However, these drugs also can increase the risk of bleeding. Increased bleeding is especially a concern when someone is having a procedure or operation.
"There may be millions of Americans taking anticlotting drugs to prevent a stroke," said guideline author Melissa J. Armstrong, MD, an assistant professor of neurology with the University of Maryland School of Medicine in Baltimore. "For every dental procedure, minor medical procedure or surgery these people plan to have, they should work with their doctors to decide if these drugs should be continued to maintain stroke prevention efforts or temporarily stopped to lower the risk of bleeding with the procedure."
The risk of bleeding varies depending on the procedure, according to the guideline, which was developed by reviewing all available evidence to date. For many minor procedures, including dental procedures, the bleeding risk from continuing blood thinners is fairly small.
For some other procedures, the risk of bleeding may be higher when blood thinners are continued. Examples are certain hip and colon procedures.
"This guideline helps patients and doctors know what the evidence tells us about these different risks," Armstrong said. "A person's health history and preferred course of action are also important to discuss when making this decision."
Most of the studies on bleeding risks from blood thinners during procedures focus on aspirin and warfarin. Armstrong said more studies are needed to understand the bleeding risks of other blood thinners, such as clopidogrel and aspirin plus dipyridamole, as well as new anticoagulants such as dabigatran, rivaroxaban or apixaban, during or before procedures.
Some people take blood thinners for heart problems. The guideline did not review evidence for people with heart problems other than atrial fibrillation.
May is National Stroke Awareness Month.To learn more about stroke, visit
Rachel Seroka | American Academy of Neurology
Energizing the immune system to eat cancer
22.01.2019 | University of Pennsylvania School of Medicine
Early Prediction of Alzheimer’s Progression in Blood
22.01.2019 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE)
So-called bifacial stem cells are responsible for one of the most critical growth processes on Earth – the formation of wood.
Immune cells called macrophages are supposed to serve and protect, but cancer has found ways to put them to sleep. Now researchers at the Abramson Cancer...
The scientific and political community alike stress the importance of German Antarctic research
Joint Press Release from the BMBF and AWI
The Antarctic is a frigid continent south of the Antarctic Circle, where researchers are the only inhabitants. Despite the hostile conditions, here the Alfred...
World first experiments on sensor that may revolutionise everything from medical devices to unmanned vehicles
The new sensor - capable of detecting vibrations of living cells - may revolutionise everything from medical devices to unmanned vehicles.
Dead and alive at the same time? Researchers at the Max Planck Institute of Quantum Optics have implemented Erwin Schrödinger’s paradoxical gedanken experiment employing an entangled atom-light state.
In 1935 Erwin Schrödinger formulated a thought experiment designed to capture the paradoxical nature of quantum physics. The crucial element of this gedanken...
16.01.2019 | Event News
14.01.2019 | Event News
12.12.2018 | Event News
22.01.2019 | Life Sciences
22.01.2019 | Architecture and Construction
22.01.2019 | Life Sciences